AI assistant
Laurus Labs Limited Major Shareholding Notification 2020
62639_rns_2020-10-29_bbb0098b-deaf-4a82-8779-6bb1b5c2f134.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
October 29, 2020
| To | To |
|---|---|
| The Corporate Relations Department BSE Limited Phiroz Jeejeebhoy Towers, 25th Floor, Dalal Street Mumbai - 400001 |
The Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051 |
| Code: 540222 | Code: LAURUSLABS |
Dear Sirs,
Sub: Approval Letter for reclassification of Shareholding from Promoter Category to Public Category
Ref: Our disclosures dated March 12, 2020, July 09,2020 and July 20, 2020
Further to our disclosures dated March 12, 2020, July 09, 2020 and July 20, 2020 regarding the reclassification of Shareholding of Dr. Srihari Raju Kalidindi and his Immediate Relatives from Promoter Category to Public Category, pursuant to Regulation 31A of SEBI (LODR) Regulations, 2015, we wish to inform that the Company has received approval from National Stock Exchange of India Limited and BSE Limited ("Stock Exchanges") on October 28, 2020 for reclassification of Shareholding of Dr. Srihari Raju Kalidindi and his Immediate Relatives from Promoter Category to Public Category. (Enclosed the copy of the approval letters received from the Stock Exchanges).
This is for your information and records.
Thanking you,
Yours sincerely, For Laurus Labs Limited
V.V. Ravi Kumar Executive Director & Chief Financial Officer
Encl: As above
Registered Office : Plot No:21, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam - 531021, Andhra Pradesh, India. CIN : L2~239AP2005PLCO~ 7518 T +91 891 660 1222, 306 1222, F +91 891 660 1270, 306 1270, E [email protected] W lauruslabs.com
LAURUS Generics LAURUS Generics LAURUS Synthesis LAURUS Ingredients Active Pharmaceutical Ingredients & Intermediates Finished Dosage Forms Contract Development & Manufacturing Services Specialty Ingredients for Nutraceutical & Allied Industry
Ref: NSE/LIST/83 October 28, 2020
The Company Secretary Laurus Labs Limited Plot No.21, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam - 531021.
Sub : Approval for Reclassification of Promoters under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam,
This has reference to your application dated July 20, 2020 seeking Reclassification of Promoters under the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Based on submissions made by the company, the Exchange is pleased to approve your application for reclassification of following Promoter as per the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Sr. No. | Name |
|---|---|
| 1 | Kalidindi Srihari Raju |
| 2 | Vijaya Durga Chintalapati |
| 3 | Jayapadma Chintalapati |
You are required to ensure that the event of reclassification shall be disclosed to the Exchange as a material event in accordance with the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Yours faithfully, For National Stock Exchange of India Ltd.
Charmi Dharod Manager
CC: National Securities Depository Limited
4th Floor, Trade world, Kamala Mills Compound, Senapati Bapat Marg., Lower Parel, Mumbai - 400 013 Central Depository Services Limited P.J.Towers, 28th Floor, Dalal Street, Mumbai - 400 073
From: Mangalam Iyer Mangalam.Iyer@bseindia.com Sent: Wednesday, October 28, 2020 3:59:10 PM To: [email protected] secretarial@lauruslabs.com; [email protected] info@lauruslabs.com Cc: Regulation 30 bse.regulation30@bseindia.com Subject: FW: Approval letter for Reclassification of Shareholders under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
CAUTION: This email originated from outside Laurus. Do not click links or open attachments unless you recognize the sender and know the content is safe.
The Company Secretary/ Compliance Officer Laurus Labs Ltd. Plot No.21, Jawaharlal Nehru Pharma City, Parawada, Visakapatnam, Andhra Pradesh, 531021
Sub: Approval letter for Reclassification of Shareholders under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/Madam,
We refer to your application dated July 20, 2020 seeking Reclassification of Promoter Shareholders under the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Exchange is pleased to approve your application for Reclassification of Promoter Shareholders under the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 based on submissions made by the company.
Entities mentioned in Annexure 1 shall be classified as public shareholders whereas entities mentioned in Annexure 2 shall continue to be the promoters of the company.
The summary of the Shareholding Pre-Reclassification & Post-Reclassification is as follows:
| Quarter | Promoter holding | Public Holding | ||
|---|---|---|---|---|
| Shares Held | Percentage | Shares Held | Percentage | |
| Pre-Reclassification | 3,43,50,523 | 32.13 | 7,25,63,976 | 67.87 |
| Post-Reclassification | 3,07,72,632 | 28.78 | 7,61,41,867 | 71.22 |
This letter may be forwarded to the depositories and your RTA for necessary action at their end.
Yours faithfully,
Abhijit Pai Mangalam Iyer Deputy General Manager Assistant Manager Listing Compliance Listing Compliance
Encl. Annexure 1 - Details of Outgoing Promoters
Annexure 2 - Details of Remaining Promoters
| ANNEXURE I | ||||||
|---|---|---|---|---|---|---|
| Sr. No. | Name of the Outgoing Promoters | No. of shares | % Holding | |||
| 1 | VIJAYA DURGA CHINTALAPATI | 2,00,000 | 0.04 | |||
| 2 | KALIDINDI SRIHARI RAJU | 1,74,89,455 | 3.26 | |||
| 3 | JAYAPADMA CHINTALAPATI | 2,00,000 | 0.04 | |||
| TOTAL | 1,78,89,455 | 3.34 |
Annexure 1 – Details of Outgoing Promoters
Annexure 2 – Details of Remaining Promoters
| Sr. No. | Name of the Remaining Promoters | No. of shares | % Holding |
|---|---|---|---|
| 1 | SATYANARAYANA CHAVA | 9,41,94,020 | 17.57 |
| 2 | VENKATA RAVI KUMAR VANTARAM | 81,05,000 | 1.51 |
| 3 | CHAVA NARASIMHA RAO | 1,19,675 | 0.02 |
| 4 | CHANDRA KANTH CHEREDDI | 30,000 | 0.01 |
| 5 | NAGA RANI CHAVA | 3,69,32,720 | 6.89 |
| 6 | CHUNDURU VENKATA LAKSHMANA RAO | 1,38,50,145 | 2.58 |
| 7 | KRISHNAVENI VASIREDDI | 2,01,150 | 0.04 |
| 8 | SEKHAR BABU CHUNDURU | 1,00,000 | 0.02 |
| 9 | HYMAVATHI VANTARAM | 2,25,000 | 0.04 |
| 10 | SOUMYA CHAVA | 6,000 | 0 |
| 11 | NAGAMANI THOKALA | 1,00,000 | 0.02 |
| 12 | KAMALA KOMMANA | 1,00,000 | 0.02 |
| 13 | RAMA SURYADEVARA | 1,70,000 | 0.03 |
| 14 | NARASIMHA RAO SURYADEVARA | 1,47,500 | 0.03 |
| TOTAL | 15,42,81,210 | 28.78 |
Note: Due to ongoing lockdown situation we are sending confirmation regarding Approval of your reclassification application through email. Hard copy of the Approval Letter shall be sent later.
Regards, Mangalam Iyer Assistant Manager Listing Compliance
BSE Limited, P J Towers, Dalal Street, Mumbai -400001, India Phone (Direct) : 22 22725780
World's Fastest Exchange With A Speed Of 6 Microseconds
This mail is classified as 'BSE - PUBLIC' by Mangalam.Iyer on October 28, 2020 at 15:59:08.
DISCLAIMER : The contents of this message may be legally privileged and confidential and are for the use of the intended recipient(s) only. It should not be read, copied and used by anyone other than the intended
recipient(s). If you have received this message in error, please immediately notify the sender, preserve its confidentiality and delete it. Before opening any attachments please check them for viruses and defects. DISCLAIMER : The contents of this message may be legally privileged and confidential and are for the use of the intended recipient(s) only. It should not be read, copied and used by anyone other than the intended recipient(s). If you have received this message in error, please immediately notify the sender, preserve its confidentiality and delete it. Before opening any attachments please check them for viruses and defects.